US 6,943,166 B1
Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunctionGeneral
US 6,943,166 B1
Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Rebecca Cook
Art Unit:
1614 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
Inventors:
William Ernest Pullman; John Steven Whitaker
Assignee:
Priority:
04/30/99
Filed:
04/26/00
Granted:
09/13/05
Expiration:
04/30/19
Abstract
The present invention relates to highly selective phosphodieterase (PDE) enzyme inhibitors and to their use in pharmaceutical articles of manufacture. In particular, the present invention relates to potent inhibitors of cyclic guanosine 3′,5′-monophosphate specific phosphodiesterase type 5 (PDE5) that when incorporated into a pharmaceutical product at about 1 to about 20 mg unit dosage are useful for the treatment of sexual dysfunction.